Trial Profile
Phase I/II study of nilvadipine in patients with Alzhiemer's disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Aug 2011
Price :
$35
*
At a glance
- Drugs Nilvadipine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 22 Sep 2006 New trial record.